104-Week RCT Finds Diet Drinks Match Water for Weight Loss Maintenance
The longest RCT to date shows non-nutritive sweetened beverages perform equivalently to water for weight loss and maintenance over two years. Industry funding and structured behavioral support limit generalizability, yet the data challenge WHO guidance derived from weaker observational evidence. Larger independent trials are needed to guide public-health recommendations.
The double-blind randomized trial assigned participants to a structured behavioral program plus either commercially available diet drinks or water for 104 weeks. Daily sweetener intake stayed below EFSA limits. Both arms showed sustained reductions in weight, waist circumference, body fat, and metabolic markers through the maintenance phase without researcher contact. Sugar intake dropped in both groups, slightly more among diet-drink users. No between-group differences emerged in blood pressure, lipids, or appetite measures. The industry-funded study declared independent analysis and reporting, yet the American Beverage Association support still invites scrutiny given historical patterns of selective emphasis in sweetener research. Results directly counter WHO's 2023 observational-based caution by supplying the longest RCT data to date, building on the team's 2023 International Journal of Obesity findings that short-term appetite regulation was also unaffected. Future policy updates will likely hinge on whether additional independent replications in diverse populations confirm these metabolic neutrality findings. Regulators may also examine whether the structured program itself drove adherence more than beverage choice.
WHO: Will issue updated sweetener guidance within 24 months incorporating at least two new long-term RCTs showing neutral weight effects.
Sources (3)
- [1]Primary Source(https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/switch-trial-nns-beverages-weight-management)
- [2]Supporting Source(https://www.nature.com/articles/s41366-023-01345-6)
- [3]Supporting Source(https://www.who.int/news/item/2023-05-15-who-advises-against-use-of-non-sugar-sweeteners)
Corrections (1)
The double-blind randomized trial lasted 104 weeks
The SWITCH trial was a 104-week parallel-group, open-label, randomized controlled equivalence trial (not double-blind) involving 493 adults. It included a 52-week assisted behavioral weight management program followed by 52 weeks unassisted monitoring, with primary endpoint at week 104. Multiple sources, including the published paper in British Journal of Nutrition, explicitly describe it as open-label.